News & Highlights
University & Community News & Highlights
- The Powell Center would like to Congratulate Jean Wyman, Co-Director of the Powell Center, for receiving the Nurse Leader in Aging Award - Jean Wyman received the Nurse Leader in Aging Award from the American Academy of Nursing for revolutionary research and leadership on continence and healthy aging.
- University of Pennsylvania, Department of Medicine has retained Tyler & Company for an exciting search for a Chief of General Internal Medicine - Penn Medicine is committed to remain a world-leading institution in three equally valued and inter-related missions of patient care, education, and research. The success of these missions requires the integration of the School of Medicine and Health Services and a shared destiny with the University of Pennsylvania. By recruiting and retaining a world-class faculty and staff who strive for excellence, innovation, quality, and professionalism, we will accomplish our missions.
- Identifying the Biological Clock that governs Female Fertility- The biological clock that governs female fertility has been identified by researchers. The discovery represents a major contribution to research aimed at finding medical approaches to treating infertility in women.
- Genetic Variant protects some Latina Women from Breast Cancer - A genetic variant common in Latina women protects against breast cancer, an international research collaboration has found. The variant, a difference in just one of the three billion "letters" in the human genome known as a single-nucleotide polymorphism (SNP), originates from indigenous Americans and confers significant protection from breast cancer, particularly the more aggressive estrogen receptor-negative forms of the disease, which generally have a worse prognosis.
- Personalized Ovarian Cancer Vaccines set for Human Trials - It may not be too long before there is a personalized vaccine to treat patients with ovarian cancer, according to a new study. Researchers from the University of Connecticut say the vaccine stems from a new technique that identifies protein mutations in cancer cells, and the method is already set to enter human trials.